Methionine as a double-edged sword in health and disease: Current perspective and future challenges
dc.contributor.author | Navik, Umashanker | |
dc.contributor.author | Sheth, Vaibhav G. | |
dc.contributor.author | Khurana, Amit | |
dc.contributor.author | Jawalekar, Snehal Sainath | |
dc.contributor.author | Allawadhi, Prince | |
dc.contributor.author | Gaddam, Ravinder Reddy | |
dc.contributor.author | Bhatti, Jasvinder Singh | |
dc.contributor.author | Tikoo, Kulbhushan | |
dc.date.accessioned | 2024-01-21T10:54:59Z | |
dc.date.accessioned | 2024-08-14T07:44:17Z | |
dc.date.available | 2024-01-21T10:54:59Z | |
dc.date.available | 2024-08-14T07:44:17Z | |
dc.date.issued | 2021-10-25T00:00:00 | |
dc.description.abstract | Methionine is one of the essential amino acids and plays a vital role in various cellular processes. Reports advocate that methionine restriction and supplementation provide promising outcomes, and its regulation is critical for maintaining a healthy life. Dietary methionine restriction in houseflies and rodents has been proven to extend lifespan. Contrary to these findings, long-term dietary restriction of methionine leads to adverse events such as bone-related disorders, stunted growth, and hyperhomocysteinemia. Conversely, dietary supplementation of methionine improves hepatic steatosis, insulin resistance, inflammation, fibrosis, and bone health. However, a high level of methionine intake shows adverse effects such as hyperhomocysteinemia, reduced body weight, and increased cholesterol levels. Therefore, dietary methionine in a safe dose could have medicinal values. Hence, this review is aimed to provide a snapshot of the dietary role and regulation of methionine in the modulation of health and age-related diseases. � 2021 Elsevier B.V. | en_US |
dc.identifier.doi | 10.1016/j.arr.2021.101500 | |
dc.identifier.issn | 15681637 | |
dc.identifier.uri | https://kr.cup.edu.in/handle/32116/4299 | |
dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S1568163721002476 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.subject | Aging | en_US |
dc.subject | AMPK | en_US |
dc.subject | FGF-21 | en_US |
dc.subject | Insulin sensitivity | en_US |
dc.subject | Methionine restriction | en_US |
dc.subject | Methionine supplementation | en_US |
dc.subject | mTOR | en_US |
dc.title | Methionine as a double-edged sword in health and disease: Current perspective and future challenges | en_US |
dc.title.journal | Ageing Research Reviews | en_US |
dc.type | Short survey | en_US |
dc.type.accesstype | Closed Access | en_US |